ANI Pharmaceuticals, Inc. (ANIP) vs Xeris Biopharma Holdings, Inc. (XERS)

ANI Pharmaceuticals, Inc. and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. and Xeris Biopharma Holdings, Inc. are of similar size ($1.7B and $1.6B). Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 15.3×. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 36.3% against 30.9%. ANI Pharmaceuticals, Inc. has the higher net margin (11.0% vs −5.12%) and the lower return on invested capital (11.3% vs 18.9%). Across the 19 metrics below, ANI Pharmaceuticals, Inc. leads on 13 and Xeris Biopharma Holdings, Inc. on 6.